Evidence map›Paper›PMID 16443680›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms.

Qing Ge, Phillip D Holler, Vinay S Mahajan, Tam Nuygen, Herman N Eisen, Jianzhu Chen

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Stage-dependent reactivity of thymocytes to self-peptide--MHC complexes.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qing GeCenter for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Phillip D Holler
Vinay S Mahajan
Tam Nuygen
Herman N Eisen
Jianzhu Chen

Funding

Control of V(D)J Recombination at the TCR beta LocusR01AI040146 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CHEN, JIANZHU · 1997 to 2007
$2.1M
Regulation of Ras signaling by the ubiquitin pathwayR01CA140451 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI PFLEGER, CATHIE M · 2009 to 2013
$1.6M
Regulation of T Cell HomeostasisR01AI050631 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CHEN, JIANZHU · 2002 to 2006
$1.6M
PEPTIDES/MHC I COMPLEXES AND CD8+ T CELLSR01CA060686 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI EISEN, HERMAN N · 1993 to 2004
$1.3M
NCI NIH HHS CA140451NCI NIH HHS CA60686NCI NIH HHS R01 CA060686NCI NIH HHS R01 CA140451NIAID NIH HHS AI40146NIAID NIH HHS AI50631NIAID NIH HHS R01 AI040146NIAID NIH HHS R01 AI050631
6 · The paper itself

Abstract

Differences in T cell receptor (TCR) signaling initiated by interactions among TCRs, coreceptors, and self-peptide-MHC complexes determine the outcome of CD4 versus CD8 lineage of T cell differentiation. The H-2Ld and Kbm3 alloreactive 2C TCR is positively selected by MHC class I Kb and a yet-to-be identified nonclassical class I molecule to differentiate into CD8+ T cells. Here we describe two mechanisms by which CD4+ 2C T cells can be generated in 2C TCR-transgenic mice. In the RAG-/- background, development of CD4+ 2C T cells requires the expression of both I-Ab and the TAP genes, indicating that both MHC class I and II molecules are required for positive selection of these T cells. Notably, only some of the 2C+ RAG-/- mice (approximately 30%) develop CD4+ 2C T cells, with frequencies in individual mice varying from 0.5% to as high as approximately 50%. In the RAG+ background, where endogenous TCRalpha genes are rearranged and expressed, CD4+ 2C T cells are generated because these cells express the 2C TCR as well as additional TCRs, consisting of the 2C TCRbeta and endogenous TCRalpha chains. Similarly, T cells expressing the OT-1 TCR, which is nominally MHC class I-restricted, can also develop into CD4+ T cells through the same two mechanisms. Thus, expression of two TCRs by a single thymocyte, TCR recognition of multiple MHC molecules, and heterogeneity of TCR, coreceptors, and peptide-MHC interactions in the thymus all contribute to the outcome of CD4 versus CD8 lineage development.

Indexed as

AnimalsCD4-Positive T-LymphocytesCell LineHistocompatibility Antigens Class IHistocompatibility Antigens Class IIMiceMice, Inbred C57BLMice, KnockoutModels, ImmunologicalReceptors, Antigen, T-CellHistocompatibility Antigens Class IHistocompatibility Antigens Class IIReceptors, Antigen, T-Cell

Identifiers

PMID16443680
PMCPMC1413658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.